Circulating Neurofilament Light Chain Levels Increase with Age and Are Associated with Worse Physical Function and Body Composition in Men but Not in Women
暂无分享,去创建一个
M. Cascante | X. Capó | Margalida Torrens-Mas | A. M. Galmés-Panadés | L. Masmiquel | Cayetano Navas-Enamorado | A. Galmés-Panadés | A. Ortega-Moral | Andrés Sánchez-Polo | S. Marín | M. Gonzalez-Freire | Silvia Marín | A. Ortega-Moral
[1] Toshiko Tanaka,et al. Plasma metabolomic signatures of dual decline in memory and gait in older adults , 2023, GeroScience.
[2] U. Himmelreich,et al. Body fat and components of sarcopenia relate to inflammation, brain volume, and neurometabolism in older adults , 2023, Neurobiology of Aging.
[3] R. McIntosh,et al. Neutrophil-to-Lymphocyte Ratio Amplifies the Effects of Aging on Decrements in Grip Strength and its Functional Neural Underpinnings. , 2023, The journals of gerontology. Series A, Biological sciences and medical sciences.
[4] J. Faul,et al. Grip strength is inversely associated with DNA methylation age acceleration , 2022, Journal of cachexia, sarcopenia and muscle.
[5] J. Wellmann,et al. Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters , 2022, Scientific Reports.
[6] D. Scheinost,et al. Associations between grip strength, brain structure, and mental health in > 40,000 participants from the UK Biobank , 2022, BMC Medicine.
[7] Joshua L. Keller,et al. An examination of the relationship among plasma brain derived neurotropic factor, peripheral vascular function, and body composition with cognition in midlife African Americans/Black individuals , 2022, Frontiers in Aging Neuroscience.
[8] R. Segurado,et al. Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: findings from GenoFit , 2022, Journal of cachexia, sarcopenia and muscle.
[9] L. Ferrucci,et al. Longitudinal associations of absolute versus relative moderate-to-vigorous physical activity with brain microstructural decline in aging , 2022, Neurobiology of Aging.
[10] Omar H. Butt,et al. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage , 2022, Neurobiology of Disease.
[11] O. Bruyère,et al. Neurofilament light chain concentration in an aging population , 2022, Aging Clinical and Experimental Research.
[12] Bernice Lin,et al. Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo? , 2021, Frontiers in Molecular Neuroscience.
[13] C. Enzinger,et al. Factors influencing serum neurofilament light chain levels in normal aging , 2021, Aging.
[14] C. Jack,et al. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes , 2021, Alzheimer's research & therapy.
[15] C. Jack,et al. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes , 2021, Alzheimer's Research & Therapy.
[16] P. Avoni,et al. Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study , 2021, Frontiers in Aging Neuroscience.
[17] J. Trojanowski,et al. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease , 2021, Movement disorders : official journal of the Movement Disorder Society.
[18] K. Hutchison,et al. Investigating Associations Between Inflammatory Biomarkers, Gray Matter, Neurofilament Light and Cognitive Performance in Healthy Older Adults , 2021, Frontiers in Aging Neuroscience.
[19] H. Naito,et al. The 30-s chair stand test can be a useful tool for screening sarcopenia in elderly Japanese participants , 2021, BMC Musculoskeletal Disorders.
[20] A. Rainoldi,et al. Rate of Force Development as an Indicator of Neuromuscular Fatigue: A Scoping Review , 2021, Frontiers in Human Neuroscience.
[21] G. Rosania,et al. L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine , 2021, Metabolites.
[22] K. Kędziora-Kornatowska,et al. Amino Acid Levels as Potential Biomarker of Elderly Patients with Dementia , 2020, Brain sciences.
[23] H. Weiner,et al. Blood neurofilament light: a critical review of its application to neurologic disease , 2020, Annals of clinical and translational neurology.
[24] R. Benedict,et al. Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study , 2020, Multiple sclerosis.
[25] R. Bateman,et al. Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults , 2020, Alzheimer's research & therapy.
[26] S. Lehéricy,et al. Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults , 2020, Alzheimer's Research & Therapy.
[27] B. Hutter-Paier,et al. Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value , 2020, Frontiers in Neuroscience.
[28] C. Enzinger,et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes , 2020, Nature Communications.
[29] B. Polis,et al. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders , 2020, Neural regeneration research.
[30] T. Olsson,et al. Confounding effect of blood volume and body mass index on blood neurofilament light chain levels , 2020, Annals of clinical and translational neurology.
[31] L. Tan,et al. Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia , 2020, Alzheimer's & dementia.
[32] L. Tan,et al. Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. , 2019, Journal of Alzheimer's disease : JAD.
[33] C. Jack,et al. Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin , 2019, Alzheimer's & Dementia.
[34] I. Kwon,et al. Associations Between Skeletal Muscle Mass, Grip Strength, and Physical and Cognitive Functions in Elderly Women: Effect of Exercise with Resistive Theraband , 2019, Journal of exercise nutrition & biochemistry.
[35] K. Blennow,et al. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. , 2019, JAMA neurology.
[36] P. Calabresi,et al. Neurofilament light chain as a biomarker in neurological disorders , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[37] J. Steinert,et al. The metabolome identity: basis for discovery of biomarkers in neurodegeneration , 2019, Neural regeneration research.
[38] L. Ferrucci,et al. Low plasma lysophosphatidylcholines are associated with impaired mitochondrial oxidative capacity in adults in the Baltimore Longitudinal Study of Aging , 2019, Aging cell.
[39] Y. Shao,et al. Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease , 2019, Molecular Neurodegeneration.
[40] R. Carson. Get a grip: individual variations in grip strength are a marker of brain health , 2018, Neurobiology of Aging.
[41] H. Lane,et al. Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging , 2017, Scientific Reports.
[42] L. Ferrucci,et al. Plasma Biomarkers of Poor Muscle Quality in Older Men and Women from the Baltimore Longitudinal Study of Aging. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.
[43] N. Danbolt,et al. Glutamate as a neurotransmitter in the healthy brain , 2014, Journal of Neural Transmission.
[44] Manuel Serrano,et al. The Hallmarks of Aging , 2013, Cell.
[45] L. Ferrucci,et al. Trajectories of gait speed predict mortality in well-functioning older adults: the Health, Aging and Body Composition study. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.
[46] S. Studenski,et al. Gait speed and survival in older adults. , 2011, JAMA.
[47] Tian-Le Xu,et al. Glycine and glycine receptor signaling in hippocampal neurons: Diversity, function and regulation , 2010, Progress in Neurobiology.
[48] John W. Olney,et al. NMDA receptor function, memory, and brain aging , 2000, Dialogues in clinical neuroscience.
[49] L. Ferrucci,et al. Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18: 2 Predicts Greater Decline of Gait Speed in Older Adults The Baltimore Longitudinal Study of Aging , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.
[50] Peel,et al. Gait Speed as a Measure in Geriatric Assessment in Clinical Settings : A , 2012 .
[51] Lauren L. Jones,et al. Acylcarnitines: role in brain. , 2010, Progress in lipid research.